Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor 2 Substituted phenyl- (phenyl-{1- [2-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]- 1H-benzoimidazol-5-ylamine

International Journal of ChemTech Research

Volumn 2, Issue 3, 2010, Pages 1618-1633

  Sharma, Mukesh Chandra ^a   Kohli, Dharm Veer ^a   Sharma, Smita ^b  

^a DR H S GOUR UNIVERSITY   (India)

^b Yadhunath Mahavidyalya ^*  (India)

Author keywords

2 (a hydroxy benzyl) benzimidazole; AngII; Antihypertensive agents; Biphenyl tetrazole; Blood pressure

Indexed keywords

( 2 CHLOROPHENYL)(PHENYL[ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 2,3 DICHLOROPHENYL)(PHENYL [ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 2,4 DICHLOROPHENYL)(PHENYL [ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 2,5 DICHLOROPHENYL)(PHENYL [ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 2,6 DICHLOROPHENYL)(PHENYL[ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 3 CHLOROPHENYL)(PHENYL [ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; ( 4 CHLOROPHENYL)(PHENYL [ 1 [ 2' ( 1H TETRAZOL 5 YL)BIPHENYL 4 YLMETHYL] 1H BENZOIMIDAZOL 2 YL]METHYL)AMINE; 1,2 PHENYLENEDIAMINE; AMINO ACID; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; BIPHENYL TETRAZOLE; CANDESARTAN; EPROSARTAN; IRBESARTAN; LOSARTAN; MANDLIC ACID; MILFASARTAN; OLMESARTAN; PHENYL(PHENYL[ 1 [ 2 ( 1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL] 1H BENZOIMIDAZOL 5 YL)AMINE; REAGENT; SAPRISARTAN; TASOSARTAN; TELMISARTAN; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN; ZOLASARTAN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CHEMICAL REACTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; HYPERTENSION; MALE; NONHUMAN; POLYMERIZATION; RAT; SUBSTITUTION REACTION; SYSTOLIC BLOOD PRESSURE;

EID: 77957351503     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wexler, R. R.; Greenlee, W. J.; Irvin, J. D.; Goldberg, M. R.;Prendergast, K.; Smith, R. D.; Timmermans, P. B. M. W. M. Nonpeptide Angiotensin II Receptor Antagonists: The Next Generationin Antihypertensive Therapy. J. Med. Chem. 39, 625-656(1995).
2. Schmidt, B.; Schieffer, B. Angiotensin II AT1 Receptor Antagonist. Clinical Implications of Active Metabolites. J. Med. Chem. 46, 2261-2270(2003).
3. Ferrario, C. M. The Renin-Angiotensin System: Importance in Physiology and Pathology. J. Cardiovasc. Pharmacol. 15 (Suppl. 3), 51-55(1990).
4. Vallotton, M. B. The Renin-Angiotensin System. Trends Pharmacol. Sci. 1987, 8, 69.
5. Nahmias, C.; Strosberg, A. D. The angiotensin AT2 Receptor: Searching for Signal-Transduction Pathways and Physiological Function. Trends Pharmacol. Sci. 16, 223-225(1995).
6. Berecek, K. H.; King, S. J.; Wu, J. N. Angiotensin-Converting Enzyme and Converting Enzyme Inhibitors. Cellular and Molecular Biology of the Renin-Angiotensin System; CRC Press: Boca Raton, FL, 183-220(1994).
7. Kleinert, H. D. Recent Developments in Renin Inhibitors. Exp. Opin. Invest. Drugs, 3, 1087-1104(1994).
8. A.S. Dutta, Design and Therapeutic Potential of Peptides. In Advances in Drug Research; Testa, B., Ed. Academic Press: London, 21, 147-286(1991).
9. J.R. McEwan, R.W. Fuller, Angiotensin Converting Enzyme Inhibitors and Cough. J. Cardiovasc. Pharmacol. 13 (Suppl. 3), S67-S69 (1989).
10. R.A. Skidgel, S. Engelbrecht, A.R. Johnson, E.G. Erdos. Hydrolysis of Substance P and Neurotensin by Converting Enzyme and Neutral Endopeptidase. Peptides. 5: 769-776(1984).
11. Y. Furukawa, S. Kishimoto, S. Nishikawa. U.S. Patent 4340598, (1982).
12. D. J. Carini, J.V. Duncia, P. E. Aldrich, A.T. Chiu, A.L. Johnson, M.E. Pierce, W.A. Price, J.B. Santella, G.J. Wells, R.R. Wexler, P.C. Wong, S. Yoo, P.B.M.W. Timmermans. J. Med. Chem. 34, 2525-2547(1991).
13. J.A. Keiser, F.A. Bjork. Pharmaco. Exp Ther. 262, 1154-1160 (1992).
14. P. Juniak, A. Pillon. Hypertension. 20(6): 737-745(1992).
15. D.A. Scheur, M.H. Perrone. Am J Physiol Regul Integr Comp Physiol. 264: 917-923 (1993).
16. K. Kubo, Y. Kohara, E. Imamiya, Y. Sugiura, Y. Inada, Y. Furukawa, K. Nishikawa, T. Naka, J. Med. Chem. 36, 2182-2195(1993).
17. U.J. Ries, G. Mihm, B. Narr, K.M. Hasselbach, H. Wittneben, M. Entzreoth, J.C.A. Van Meel, M. Wienen, N.H. Hauel, J. Med. Chem. 36, 4040-4051(1993).
18. W.T. Ashton, C.L. Cantone, L.L. Chang, S.M. Hutchins, R.A. Strelitz, M. Maccoss, R.S.L. Chang, V.J. Lotti, K.A. Faust, T. Chen, P. Bunting, T.W. Schorn, S.D. Kivlighn, P.K.S. Siegel, J. Med. Chem. 36, 591-609(1993).
19. A. Bali, Y. Bansal, M. Sugumaran, J.S. Saggu, P. Balakumar, G. Kaur, G. Bansal, A. Sharma, M. Singh, Bioorg. Med. Chem. Lett. 15, 3962-3965(2005).
20. R.K. Jat, J.L. Jat, D.P. Pathak., Synthesis of Benzimidazole Derivatives: As Anti-hypertensive Agents. E Journal of Chemistry. 3: 13, 278-285, (2006).
21. Preston, Heterocyclic Compounds: Benzimidazoles and Congeneric Tricyclic compounds, Part-I, Vol-40, p-7.
22. Solomon Marmor, Laboratory methods in Organic Chemistry, Surjeet publications, p-284-285(1986).
23. F. Gualtieri, G. Brody, A.H. Filedsteel and W.A. Skinar, J. Med. Chem, 14, 546(1971).
24. Sarhan, Hozien, Mahmoud, J. Chinese chem. soc., Vol. 47, PP 1279-1286(2000).
25. M.R. Grimmett. In Comprehensive Heterocyclic Chemistry. The Structure, Reactions, Synthesis and Uses of Heterocyclic Compounds. Potts, K.T., Ed.; Pergamon: Oxford, Vol. 5; 429.
26. B.S. Furniss, A.J. Hannaford, W.G. Peter, T. Smith, A.R. Tetchell, Vogel's Text book of Practical Organic Chemistry, 5 ed., Longman Scientific and Technical, England, 1989; 1163.
27. G.W. Kenner, M.J.T. Robinson, C.M.B. Tylor, B. R. Webster. Reactions between strongly basic nucleophiles and fluorenones J. Chem. Soc. 1756(1962).
28. D.K. Badyal, H. Lata, A.P. Dadhich. Indian. J. of pharmacology 35, 66, 349-362, (2003).
29. R.D. Bunag. J.W. McCubbin, I.H. Page. Lack of correlation between direct and indirect measurements of arterial pressure in unanaesthetized rats. Cardiovascular Res. 5(1): 24-31 (1971).
30. A.A. Siddiqui, M.S. Wani. Indian. j. chemistry. 43B, 1574, 1579(2004).
31. S.K. Gupta. Drug Screening methods, Jaypee Brothers Medical Publisher, New Delhi, pp 236-246, (2004).